Europe approves childhood epilepsy treatment
UCB’s FINTEPLA (fenfluramine) oral solution has been approved in the European Union (EU) for the…
February 10, 2023 - 3 minutes
Epilepsy
Metrion and KCNC1 Foundation announce collaboration to identify therapeutic
Metrion Biosciences Limited, and The KCNC1 Foundation are to collaborate to try and find a…
December 8, 2022 - 2 minutes
Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years
Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS)…
December 7, 2022 - 3 minutes
UCB publishes Lennox-Gastaut syndrome study data
UCB has announced the publication of long-term open-label extension (OLE) study results of FINTEPLA (fenfluramine)…
November 23, 2022 - 4 minutes
Researchers awarded £2M to develop drugs to prevent epileptic seizures in children
Scientists at Aston University in the U.K. have started work on a project that will…
November 15, 2022 - 3 minutes
Neuraxpharm to commercialize device giving early warning of epileptic seizures
A wearable medical device that can give an early warning of an epileptic seizure has…
October 26, 2022 - 4 minutes
Epilepsy drug accepted for review in Canada and Israel
SK Biopharmaceuticals, Co., Ltd. says Health Canada has accepted Paladin Labs Inc.'s filing of a…
August 10, 2022 - 2 minutes
New treatment option available for Dravet syndrome
Global biopharma company UCB says the UK’s National Institute for Healthcare Excellence (NICE) has issued…
June 1, 2022 - 3 minutes
Spanish Neurology Biotech Launches with €7.6M Series A
Accure Therapeutics, a neurology biotech targeting central nervous system (CNS) conditions such as multiple sclerosis…
May 29, 2020 - 3 minutes
Enormous Series A to Help Bring Epilepsy Drug to Market
One of the biggest Series A rounds in European biotech, €159M ($180M), has been raised…
February 18, 2019 - 2 minutes
Cannabinoid Drugs Company Raises $300M in Public Offering
GW Pharmaceuticals, a British biotech developing cannabinoid drugs, is on a high after a successful…
October 8, 2018 - 2 minutes
Update: The FDA Approves First Cannabinoid Treatment for Epilepsy
Update (26/06/2018): The FDA has approved GW Pharmaceutical's drug Epidiolex in two severe forms of epilepsy.…
June 26, 2018 - 2 minutes
